Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma

NCT05339113 is registered in ClinicalTrials.gov with The National Center of Oncology, Azerbaijan as lead sponsor.

NCT NCT05339113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05339113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma
Lead sponsor
The National Center of Oncology, Azerbaijan
Phase
Not applicable
Overall status
Unknown status
Start date
February 4, 2021
Completion date
December 31, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, fibroblast activation protein inhibitor, fluorodeoxyglucose f18, positron emission tomography